Tag: unc

UNC School of Medicine’s Anne Lyerly is addressing the urgent need for effective HIV prevention and treatment for the estimated 1.5 million women worldwide with HIV who give birth each year. With a $3 million NIH grant, Dr. Lyerly is leading an interdisciplinary team of researchers to determine what barriers prevent investigators from studying the virus...

On Friday December 4, 2015, Healing with CAARE, Inc. hosted its inaugural Jeanne Hopkins Lucas Education and Wellness Center Leadership Awards Gala. The Gala was planned to celebrate CAARE’s 20th Year of Service in Healthcare Innovation for Durham, NC and surrounding, while recognizing and honoring outstanding community leaders and volunteers...

In a recent interview, Dr. Christopher Hurt discussed three studies (HPTN067, the U.S. PrEP Demonstration Project and ATN110) that demonstrate the feasibility of wide-scale implementation of pre-exposure prophylaxis in the United States. Listen to the interview here.

On September 12, 2014, the Infectious Diseases Clinic at UNC Hospitals hosted a first-of-its-kind celebration gala to pay tribute to those who have been living with HIV infection for more than 20 years. Read more…

The UNC CFAR has a robust membership of doctors and researchers who work internationally to increase knowledge, decrease stigma, and provide care and support in the field of HIV/AIDS. CFAR investigator Dr. Joseph Tucker, assistant professor at the UNC School of Medicine and director of UNC Project-China, is doing innovative...

This week marks the start of the CFAR/IGHID Friday ID Conference Series for the 2014-2015 school year. Power and Sample Size Boot Camp Speakers: Michael Hudgens and Katie Mollan UNC CFAR Biostatistics Core September 5, 2014 8:30-9:30 a.m. 1131 Bioinformatics (first floor auditorium), UNC-CH Campus The CFAR Biostatistics Core will...

The UNC CFAR is getting exciting news coverage! Our researchers Katie Mollan, MS, Joe Eron, MD, Kevin Robertson, MD, and ACTG investigators have been featured in WedMD, Harvard News, and MedPage Today for their new article which explores the risks of anti-HIV drug efavirenz. This drug appears to double the...